Patents by Inventor Margit Hagel

Margit Hagel has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • INHIBITORS OF THE FIBROBLAST GROWTH FACTOR RECEPTOR 4 IN COMBINATION WITH CYCLIN-DEPENDENT KINASE INHIBITORS
    Publication number: 20190192522
    Abstract: Described herein are selective inhibitors of FGFR4, pharmaceutical compositions including such compounds, and combinations with other therapeutic agents, such as CDK inhibitors (e.g., CDK4/6 inhibitors), and methods of using such combinations.
    Type: Application
    Filed: September 8, 2017
    Publication date: June 27, 2019
    Applicant: BLUEPRINT MEDICINES CORPORATION
    Inventors: Margit HAGEL, Klaus HOEFLICH, Christoph LENGAUER, Nicolas STRANSKY, Christopher WINTER, Lan XU
  • Methods for identifying HCV protease inhibitors
    Patent number: 8603737
    Abstract: The present invention provides methods for identifying compounds useful as HCV protease inhibitors.
    Type: Grant
    Filed: September 18, 2009
    Date of Patent: December 10, 2013
    Assignee: Celgene Avilomics Research, Inc.
    Inventors: Margit Hagel, Thia B. St. Martin, Mariana S. Nacht
  • METHODS FOR IDENTIFYING HCV PROTEASE INHIBITORS
    Publication number: 20100074890
    Abstract: The present invention provides methods for identifying compounds useful as HCV protease inhibitors.
    Type: Application
    Filed: September 18, 2009
    Publication date: March 25, 2010
    Applicant: Avila Therapeutics, Inc.
    Inventors: Margit Hagel, Thia B. St. Martin, Mariana S. Nacht